PR Newswire ImmVira Reports 100% Complete Response Rate at 9 Months in Bladder Carcinoma in Situ with MVR-T3011 at ASCO by Money Compass June 1, 2026
PR Newswire 2026 ASCO | Innovent Presents Preliminary PoC Data of IBI363 (TAK-928) PD-1/IL-2α-bias bispecific fusion protein) in First-line Advanced NSCLC by Money Compass June 1, 2026
PR Newswire 2026 ASCO | Innovent Presents Long-Term Follow-up Results from the PoC Study of IBI363 (TAK-928) (PD-1/IL-2α-bias bispecific fusion protein), Showing Robust Survival Benefits in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer by Money Compass June 1, 2026
PR Newswire New Taipei City Showcases Smart Manufacturing Strength at AUTOMATE 2026 by Money Compass June 1, 2026
PR Newswire BLUETTI Launches EOFY Sale on Power Solutions with Up to 44% OFF by Money Compass May 31, 2026
PR Newswire Relief as Firmable locates 15,000 accounting decision-makers reported missing at leading global B2B data provider by Money Compass May 31, 2026
PR Newswire AI: Digital to Physical | BEYOND Expo 2026 Leads Transformative Global Direction of Tech by Money Compass May 31, 2026
PR Newswire Golden Goblet Competition Lineup Announced: Spotlight on the 2026 Contenders by Money Compass May 31, 2026
PR Newswire Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet by Money Compass May 31, 2026
PR Newswire THE KILLERS ROCK THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI® by Money Compass May 30, 2026
